70502-03-3

Basic information

• Product Name: (5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)METHANOL
• Synonyms: (5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)METHANOL;(5-Methyl-2-phenyl-1,3-oxazol-4-yl)methanol 97%;4-(Hydroxymethyl)-5-methyl-2-phenyl-1,3-oxazole 97%
• CAS NO: 70502-03-3
• Molecular Formula: C₁₁H₁₁NO₂
• Molecular Weight: 189.21
• Mol File: 70502-03-3.mol
• Article Data: 8

Chemical Properties

• Melting Point: 117 °C
• Boiling Point: 361.125°C at 760 mmHg
• Flash Point: 172.202°C
• Appearance: /
• Density: 1.176g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.567
• CAS DataBase Reference: (5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)METHANOL(CAS DataBase Reference)
• NIST Chemistry Reference: (5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)METHANOL(70502-03-3)
• EPA Substance Registry System: (5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)METHANOL(70502-03-3)

Safety Data

• Hazardous Substances Data: 70502-03-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C11H11NO2/c1-8-10(7-13)12-11(14-8)9-5-3-2-4-6-9/h2-6,13H,7H2,1H3

Upstream product

• 70501-97-2 benzimidic acid 1-methyl-prop-2-ynyl ester 
• 61151-96-0 ethyl 5-methyl-2-phenyloxazole-4-carboxylate 
• 70501-99-4 5-methyl-4-methylene-2-phenyl-4,5-dihydro-oxazole 

Downstream Products

• 70502-02-2 4-(bromomethyl)-5-methyl-2-phenyl-1,3-oxazole 
• 906072-30-8 (5-methyl-2-phenyl-1,3-oxazol-4-yl)methyl methanesulfonate 
• 132451-15-1 N-methyl-N-<(5-methyl-2-phenyl-4-oxazolyl)methyl>-4<(2,4-dioxothiazolidin-5-yl)methyl>benzenesulfonamide 
• 132451-19-5 N-methyl-N-<(5-methyl-2-phenyl-4-oxazolyl)methyl>-4<(2,4-dioxothiazolidin-5-yl)methyl>benzamide 
• 132451-17-3 N-methyl-N-<(5-methyl-2-phenyl-4-oxazolyl)methyl>-4<(2,4-dioxothiazolidin-5-ylidene)methyl>benzamide 
• 141200-22-8 5-{4-[(E)-3-(5-Methyl-2-phenyl-oxazol-4-yl)-acryloyl]-benzyl}-thiazolidine-2,4-dione 
• 132451-31-1 4-methylaminocarbonyl>benzaldehyde 
• 132451-29-7 N-methyl-N-[(5-methyl-2-phenyl-4-oxazolyl)-methyl]amine 
• 166254-17-7 2-(5-methyl-2-phenyl-oxazol-4-ylmethoxy)-5-[3-(1H-tetrazol-5-yl)-propyl]-pyridine 
• 166253-87-8 methyl 2-bromo-3-[6-(5-methyl-2-phenyl-4-oxazolylmethoxy)-3-pyridyl]propionate 
• 166253-89-0 (E)-3-[6-(5-methyl-2-phenyl-4-oxazolylmethoxy)-3-pyridyl]-2-propen-1-ol 
• 178238-83-0 (E)-[3-fluoro-4-(5-methyl-2-phenyl-4-oxazolylmethoxy)]cinnamaldehyde 
• 166253-88-9 methyl (E)-3-[6-(5-methyl-2-phenyl-4-oxazolylmethoxy)-3-pyridyl]acrylate 
• 178610-64-5 3-fluoro-4-(5-methyl-2-phenyl-4-oxazolylmethoxy)aniline 

Relevant articles and documents

NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME

The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPARγ) and alpha (PPARα), processes of preparing the same, and pharmaceutical compositions containing the same as an active agent.

Carboxylic acid derivatives and drugs containing the same as the active ingredient

A peroxisome proliferator activated receptor regulator containing a compound of formula (I) (wherein all symbols are as defined in the specification), or a salt thereof as active ingredient. Because of having an effect of regulating PPAR, a compound of fo

Substituted oxazoles and thiazoles derivatives as hPPARγ and hPPARα activators

The present invention discloses compounds of formula (I), and tautomeric forms, pharmaceutically acceptable salts, or solvates thereof. Preferably, the compounds of the invention are dual activators of hPPARγ and hPPAR{acute over (α)}.